EW insider transactions
Edwards Lifesciences Corporation (EW) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
EW insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Edwards Lifesciences Corporation, latest first. Follow anyone to get their next filing.
- Wayne MarkowitzCvp, Japac, since August 2023-$1.11M
- Andrew M. DahlSVP, Corporate Controller, since July 2024-$98.4K
- Daveen ChopraCVP, TMTT, Surgical & IHFM-$11.1M
- Daniel J. LippisCvp, Tavr, since January 2024-$1.85M
- Annette BrulsCvp, Emeacla, since August 2024-$238K
- Bernard J ZovighianCEO, Director, since May 2022+$49.8K-$12.2M
- Theodora MistrasCVP, Chief Financial Officer, since May 2026
- Donald E Bobo JrCVP,Strategy/Corp Development-$48.3M
- Scott B. UllemCVP, Chief Financial Officer-$21.4M
- Nicholas J ValerianiDirector+$168K-$699K
- Steven R LorangerDirector-$439K
- Ramona SequeiraDirector
- David T FeinbergDirector, since July 2024
- Paul A LavioletteDirector
- Heisz Leslie StoneDirector-$2.92M
- Kieran GallahueDirector-$3.84M
- Leslie C. DavisDirector, since May 2024
- Larry L WoodGlobal President TAVR & Surg-$22.9M
- Catherine M. SzymanCVP, Critical Care-$31.9M
- Jean-Luc M LemercierCVP, EMEACLA and JAPAC-$13.2M
- Robert W.a. SellersSVP, Corporate Controller-$3.3M
- Michael A MussallemDirector-$118M
- Martha H. MarshDirector-$3.1M
- Huimin WangOfficer-$12.1M
Recent Form 3, 4, and 5 filings for EW
- CVP, TAVR Lippis Daniel J. sold $53,017 worth of shares (619 units at $85.65) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SVP, Corporate Controller Dahl Andrew M. sold $49,534 worth of shares (544 units at $91.06), decreasing direct ownership by 4% to 14,868 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, EMEACLA Bruls Annette sold $237,907 worth of shares (2,644 units at $89.98), decreasing direct ownership by 13% to 17,984 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TMTT, Surgical & IHFM Chopra Daveen exercised 31,800 shares at a strike of $72.68 and sold $2,894,440 worth of shares (31,800 units at $91.02) (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, JAPAC Markowitz Wayne sold $113,417 worth of shares (1,240 units at $91.47), decreasing direct ownership by 6% to 20,294 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, JAPAC Markowitz Wayne sold $12,588 worth of shares (146 units at $86.03), decreasing direct ownership by 0.67% to 21,534 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, JAPAC Markowitz Wayne exercised 9,628 shares at a strike of $74.02 and sold $818,958 worth of shares (9,628 units at $85.06) (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CEO Zovighian Bernard J gifted 320 shares, received a gift of 320 shares and sold $245,134 worth of shares (2,921 units at $83.93), decreasing direct ownership by 0.32% to 98,845 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, EMEACLA Bruls Annette covered exercise/tax liability with 109 shares, decreasing direct ownership by 0.53% to 20,628 units (SEC Form 4) (for withholding tax)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, Chief Financial Officer Mistras Theodora was granted 99,920 shares (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,762 worth of shares (619 units at $91.70) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 377 shares, decreasing direct ownership by 0.93% to 40,034 units (SEC Form 4) to cover taxes4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,577 worth of shares (619 units at $91.40) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CEO Zovighian Bernard J sold $45,982 worth of shares (523 units at $87.92) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SEC Form 3 filed by new insider Mistras Theodora3 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SVP, Corporate Controller Dahl Andrew M. sold $48,853 worth of shares (568 units at $86.08), decreasing direct ownership by 4% to 15,334 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $2,000,193 worth of shares (23,145 units at $86.42) (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TMTT & Surgical Chopra Daveen sold $126,905 worth of shares (1,500 units at $84.60), decreasing direct ownership by 3% to 44,324 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. exercised 620 shares at a strike of $72.68 and sold $50,307 worth of shares (620 units at $81.14) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $1,472,678 worth of shares (17,968 units at $81.96), decreasing direct ownership by 30% to 22,798 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CEO Zovighian Bernard J converted options into 47,207 shares, covered exercise/tax liability with 26,198 shares, gifted 26,640 shares, received a gift of 26,640 shares and sold $2,833,013 worth of shares (36,351 units at $77.93) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 99,165 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP,Strategy/Corp Development Bobo Donald E Jr converted options into 13,457 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 22% to 32,766 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TMTT & Surgical Chopra Daveen converted options into 13,583 shares and covered exercise/tax liability with 7,538 shares, increasing direct ownership by 15% to 45,824 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, Chief Financial Officer Ullem Scott B. covered exercise/tax liability with 11,004 shares and converted options into 19,830 shares, increasing direct ownership by 23% to 46,740 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, JAPAC Markowitz Wayne was granted 5,200 shares, covered exercise/tax liability with 490 shares and sold $47,280 worth of shares (593 units at $79.73), increasing direct ownership by 23% to 21,680 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CEO Zovighian Bernard J was granted 43,800 shares, covered exercise/tax liability with 9,551 shares, gifted 9,711 shares and received a gift of 9,711 shares, increasing direct ownership by 31% to 104,796 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 362 shares, decreasing direct ownership by 0.89% to 40,411 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Loranger Steven R was granted 4,315 shares, increasing direct ownership by 92% to 8,997 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Sequeira Ramona was granted 3,251 shares, increasing direct ownership by 92% to 6,779 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Valeriani Nicholas J was granted 5,127 shares, increasing direct ownership by 6% to 84,423 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Feinberg David T was granted 3,251 shares, increasing direct ownership by 56% to 9,087 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Gallahue Kieran was granted 4,315 shares (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Laviolette Paul A was granted 3,251 shares, increasing direct ownership by 23% to 17,552 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP,Strategy/Corp Development Bobo Donald E Jr was granted 7,850 shares and covered exercise/tax liability with 1,869 shares, increasing direct ownership by 29% to 26,778 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Stone Heisz Leslie was granted 3,251 shares, increasing direct ownership by 11% to 34,199 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, Chief Financial Officer Ullem Scott B. covered exercise/tax liability with 3,034 shares, decreasing direct ownership by 7% to 37,914 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- Director Davis Leslie C. was granted 3,251 shares, increasing direct ownership by 49% to 9,834 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 759 shares and was granted 7,850 shares, increasing direct ownership by 21% to 40,773 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 289 shares and was granted 7,005 shares, increasing direct ownership by 73% to 15,902 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TMTT & Surgical Chopra Daveen was granted 9,675 shares and covered exercise/tax liability with 1,815 shares, increasing direct ownership by 25% to 39,779 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, EMEACLA Bruls Annette was granted 6,650 shares and covered exercise/tax liability with 84 shares, increasing direct ownership by 46% to 20,737 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, Chief Financial Officer Ullem Scott B. covered exercise/tax liability with 11,751 shares and exercised 13,000 shares at a strike of $59.26, increasing direct ownership by 3% to 40,948 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CEO Zovighian Bernard J covered exercise/tax liability with 515 shares, gifted 523 shares and received a gift of 523 shares, decreasing direct ownership by 1% to 80,258 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 252 shares, exercised 2,038 shares at a strike of $59.26 and sold $170,160 worth of shares (2,038 units at $83.49) as part of a pre-agreed trading plan, decreasing direct ownership by 0.74% to 33,682 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP,Strategy/Corp Development Bobo Donald E Jr covered exercise/tax liability with 469 shares, decreasing direct ownership by 2% to 20,797 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TMTT & Surgical Chopra Daveen covered exercise/tax liability with 282 shares, decreasing direct ownership by 0.88% to 31,919 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SEC Form 4 filed by Ullem Scott B.4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SEC Form 4 filed by Lippis Daniel J.4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SEC Form 4 filed by Bobo Donald E Jr4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SEC Form 4 filed by Edwards Lifesciences Corporation4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SEC Form 4 filed by Edwards Lifesciences Corporation4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP,Strategy/Corp Development Bobo Donald E Jr exercised 11,340 shares at a strike of $59.26 and sold $974,430 worth of shares (11,340 units at $85.93) (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $2,012,076 worth of shares (24,000 units at $83.84), decreasing direct ownership by 53% to 21,266 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 176 shares, decreasing direct ownership by 2% to 9,089 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 432 shares, decreasing direct ownership by 1% to 33,934 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)